(Q53383343)

13 May 2018

title

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. (English)

1 reference

13 May 2018

1 reference

hepatocellular carcinoma

1 reference

7

Yasuhiko Sugawara

1 reference

13 May 2018

Kiyoshi Hasegawa

5

object named as

Kiyoshi Hasegawa

1 reference

13 May 2018

Eiji Tanaka

3

object named as

Eiji Tanaka

1 reference

13 May 2018

author name string

Hiroshi Imamura

1

1 reference

13 May 2018

Yutaka Matsuyama

2

1 reference

13 May 2018

Takao Ohkubo

4

1 reference

13 May 2018

Shinichi Miyagawa

6

1 reference

13 May 2018

Masami Minagawa

8

1 reference

13 May 2018

Tadatoshi Takayama

9

1 reference

13 May 2018

Seiji Kawasaki

10

1 reference

13 May 2018

Masatoshi Makuuchi

11

1 reference

13 May 2018

publication date

1 February 2003

1 reference

13 May 2018

published in

Journal of Hepatology

1 reference

13 May 2018

volume

38

1 reference

13 May 2018

page(s)

200-207

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

Early hepatocellular carcinoma as an entity with a high rate of surgical cure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Recurrence of hepatocellular carcinoma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Surgery for small liver cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Anatomy of the biliary ducts within the human liver; analysis of the prevailing pattern of branchings and the major variations of the biliary ducts

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Hepatitis C and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

Simplified staging for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900360-4

7 January 2021

10.1016/S0168-8278(02)00360-4

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

12547409

1 reference

13 May 2018